Key facts
- It has raised $690K across 1 recorded rounds; the latest was Seed Round ($690K) in Oct 2025.
- Notable investors include Wisconsin Economic Development.
- RPT Labworks has filed 1 Form D with the SEC, most recently Nov 2025 ($690K sold to 6 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for RPT Labworks
Funding rounds
1 roundsAbout RPT Labworks
Developer of preclinical research services intended for radiopharmaceutical discovery and development. The company's platform provides end-to-end support for imaging and therapeutic radionuclide studies, enabling pharmaceutical companies, biotech firms, and academic researchers to advance radiopharmaceutical programs from discovery to clinical translation.
- Sector
- Healthcare
- HQ
- Madison, WI, United States
- Founded
- 2024
- Employees
- 3
- Website
- rptlabworks.com/
- Ownership
- Privately Held (backing)
RPT Labworks doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RPT Labworks shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RPT Labworks in its N-PORT filings yet. We sweep new filings monthly.